Clinical Trials Directory

Trials / Conditions / Community-acquired Pneumonia

Community-acquired Pneumonia

205 registered clinical trials studyying Community-acquired Pneumonia31 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEarly Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failur
NCT07357935
Qingyuan ZhanPhase 1 / Phase 2
Not Yet RecruitingEfficacy of Oral Nigella Sativa as Adjuvant Therapy in Children With Moderate Persistent Asthma
NCT07315555
Tanta UniversityN/A
RecruitingFrailty and Outcomes in Older Emergency Department Patients With Pneumonia
NCT07442656
Ege University
Not Yet RecruitingPhysical Rehabilitation of Older Persons Following a Community-Acquired Infection Hospitalization - A Randomis
NCT06689280
Nordsjaellands HospitalN/A
Not Yet RecruitingCoenzyme Q10 in Pediatric Community-Acquired Pneumonia
NCT07317440
Tanta UniversityN/A
Not Yet RecruitingClinical Predictors of Severity in Pediatric Community-Acquired Pneumonia at Assiut University Children's Hosp
NCT07279675
Assiut University
RecruitingThe Fever Clinic Acute Respiratory Cohort
NCT07278700
Fudan University
RecruitingAzithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With
NCT07164131
Mayo ClinicPhase 4
RecruitingComparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
NCT06986148
Ann & Robert H Lurie Children's Hospital of ChicagoN/A
Not Yet RecruitingA Validation Study on a Prognostic Prediction Model for Respiratory Tract Infections
NCT07109310
Peking Union Medical College Hospital
Not Yet RecruitingNoninvasive Support Methods for Acute Respiratory Failure of Community-acquired Pneumonia
NCT06996834
Assiut UniversityN/A
Not Yet RecruitingAwake Prone Positioning of Patients Suffering Community Acquired Pneumonia Requiring Nasal High Flow Therapy
NCT06966310
University Hospital, ToursN/A
Not Yet RecruitingComparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone
NCT06532409
RESnTEC, Institute of ResearchN/A
RecruitingEfficacy and Safety of SR1375 in Adult Patients With CAP
NCT06577558
Shanghai SIMR Biotechnology Co., Ltd.Phase 2
Not Yet RecruitingStopping Pneumonia Antibiotherapy Regimen Early
NCT06291012
University Hospital, MontpellierPhase 4
RecruitingAmoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or
NCT06229288
Nantes University HospitalPhase 3
RecruitingOptimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy
NCT06125340
JeffreyPhase 4
RecruitingOptimizing Care for Children Hospitalized With Community-acquired Pneumonia: Novel Diagnostics
NCT06114888
JeffreyN/A
CompletedSwab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin
NCT06272994
Vanderbilt University Medical CenterN/A
UnknownStudy of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pne
NCT06334874
Future University in EgyptPhase 4
TerminatedCX-4945 in Viral Community Acquired Pneumonia
NCT06202521
Senhwa Biosciences, Inc.Phase 2
UnknownCommunity-Acquired Pneumonia Diagnosis Through Integrating Novel Microbiological Techniques.
NCT06259110
Assiut University
RecruitingAcyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL
NCT06134492
Jena University HospitalPhase 3
RecruitingClarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)
NCT06294600
Hellenic Institute for the Study of SepsisPhase 3
RecruitingCustomized Antibiotic Treatment Duration Among Hospitalized Patients With Moderately Severe Community-Acquired
NCT05903352
Assistance Publique - Hôpitaux de ParisPhase 3
CompletedEffectiveness of the PCV13 in Older Thai Adults
NCT06279624
Mahidol University
CompletedSafety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
NCT05962606
Aptarion Biotech AGPhase 2
RecruitingHigh-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia
NCT06170372
Tomsk National Research Medical Center of the Russian Academy of SciencesN/A
UnknownDuration of Antibiotic Treatment in Community-acquired Pneumonia
NCT05762328
Instituto de Investigacion Sanitaria La FeN/A
CompletedClinical Trial of the Efficacy and Safety of Raphamin in Combined Treatment of Community-acquired Pneumonia
NCT06263881
Materia Medica HoldingPhase 3
RecruitingThe Optimal Antibiotic Treatment Duration for Community-acquired Pneumonia in Adults Diagnosed in General Prac
NCT06295120
Research Unit for General Practice in AalborgPhase 4
CompletedThe Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice
NCT06210282
Aalborg UniversityN/A
UnknownRole of Multiplex PCR in CAP
NCT06097117
Assiut University
RecruitingAntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
NCT05848713
University of ManitobaPhase 3
UnknownCharacteristics of Hospitalized Patients With Community-acquired Pneumonia
NCT06065618
Qianfoshan Hospital
RecruitingEfficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
NCT05722938
BiotestPhase 3
UnknownAntibiotic Therapy In Respiratory Tract Infections
NCT04166110
Assistance Publique - Hôpitaux de ParisN/A
RecruitingFluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
NCT06029933
Kaiser Permanente
CompletedUse of Presepsin as a Marker for Immunotherapy Administration in Pneumonia
NCT05785442
Hellenic Institute for the Study of SepsisPhase 2
CompletedImproving Short Course Treatment for Common Pediatric Infections
NCT06087809
Boston Children's HospitalN/A
CompletedDiagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.
NCT05624684
Avicenna Military Hospital
UnknownThe Effect of Huashibaidu Granule on Community-acquired Pneumonia in Children
NCT05711017
Shanghai Children's Medical CenterN/A
CompletedSupportive Treatment and Antibiotics for Mild Pediatric Pneumonia
NCT05726253
Ann & Robert H Lurie Children's Hospital of ChicagoEARLY_Phase 1
CompletedImpact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community
NCT05657275
Assistance Publique - Hôpitaux de ParisN/A
CompletedHVNI vs CPAP in Children With Acute Respiratory Distress
NCT07336121
Ain Shams UniversityN/A
CompletedEfficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Pat
NCT05663905
National University of MalaysiaPhase 4
TerminatedEfficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
NCT05531149
BiotestPhase 3
UnknownCorrelation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired Pneumonia
NCT05606627
Assiut University
TerminatedA 2-Part First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of CM
NCT05629741
Clarametyx Biosciences, Inc.Phase 1
Active Not RecruitingReducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia
NCT05568654
The Cleveland ClinicN/A
CompletedUsing Electronically Derived Automated Reports of Appropriate Antibiotic Use to Inform Stewardship Interventio
NCT06027593
Children's Hospital of PhiladelphiaN/A
UnknownmNGS -Guided Antimicrobial Treatment in Early Severe Community-Acquired Pneumonia Among Immunocompromised Pati
NCT05290454
Qilu Hospital of Shandong UniversityN/A
RecruitingNeuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia
NCT05452226
University of VermontN/A
CompletedSerotype Distribution in Hospitalized Adult With Pneumococcal Community Acquired Pneumonia in France
NCT05380193
Institut National de la Santé Et de la Recherche Médicale, France
CompletedElectrical Impedance Imaging Techniques in Guiding the Use of Chest Physiotherapy in Patients with Pneumonia
NCT06642701
Capital Medical UniversityN/A
CompletedPromoting Optimal Treatment for Community-acquired Pneumonia in the Emergency Room (PIONEER)
NCT05114161
Hamilton Health Sciences CorporationN/A
WithdrawnA Pre-post Intervention Study Evaluating Home-based Management of Patients With COPD or CAP
NCT05009485
Current HealthN/A
CompletedDerivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)
NCT07425561
Azienda Ospedaliero-Universitaria Careggi
UnknownPCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study
NCT05114902
Asian Foundation for Tropical Medicine Inc.
CompletedProcalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia
NCT04963764
Ann & Robert H Lurie Children's Hospital of ChicagoEARLY_Phase 1
CompletedPostural Drainage and PEP Technique in Community Acquired Pneumonia
NCT05356494
Riphah International UniversityN/A
TerminatedTwo Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumoni
NCT04972318
Hospital do CoracaoN/A
UnknownA Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel
NCT05384314
Beaumont Hospital
CompletedAccuracy of Lung Injury Biomarkers in the Initial Investigation of Patients With Suspected Pneumonia
NCT04686331
University of Southern Denmark
CompletedOmadacycline vs. Moxifloxacin for the Treatment of Community-Acquired Bacterial Pneumonia
NCT04779242
Paratek Pharmaceuticals IncPhase 3
CompletedThe Effect of Adjunct Vitamin a on Community-Acquired Pneumonia in Southern Iranian Children: a Randomized Cli
NCT06677684
Hormozgan University of Medical SciencesN/A
CompletedAnti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
NCT04724044
Hellenic Institute for the Study of SepsisPhase 3
UnknownTCM Syndrome Differentiation Treatment on Discharged Elderly Patients With CAP
NCT04702074
Henan University of Traditional Chinese MedicineN/A
UnknownCorticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)
NCT03745664
University of Roma La SapienzaPhase 3
UnknownThe Impact of Air Pollution on the Consumption of Antimicrobials in the General Population
NCT04662047
Hospital Universitari de Bellvitge
RecruitingEvaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit
NCT04647630
Chinese University of Hong Kong
WithdrawnCorticosteroids in Community Acquired Pneumonia
NCT04652414
Vanderbilt University Medical CenterPhase 2
UnknownPneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chr
NCT04944719
Universidad de la Sabana
CompletedA Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS
NCT04612413
Enlivex Therapeutics Ltd.Phase 2
UnknownA Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired Pneumonia
NCT05002192
Beijing Grand Johamu Pharmaceutical Company, Ltd.
UnknownAssessing Effectiveness of Community Acquired Pneumonia Treatment by Continuous Pneumonia Severity Score
NCT04135183
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/A
Active Not RecruitingDischarge Stewardship in Children's Hospitals
NCT05826873
Children's Hospital of PhiladelphiaN/A
UnknownEnergy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases
NCT04415827
I.M. Sechenov First Moscow State Medical UniversityN/A
CompletedRetrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hosp
NCT04198571
Pfizer
TerminatedStudy of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumon
NCT04505605
Fondation Hôpital Saint-Joseph
CompletedPOCT PCT in Outpatient LRTI
NCT05380869
Hannover Medical SchoolN/A
TerminatedImpact of Comprehensive Molecular Tests on Antimicrobial Stewardship in Community-acquired Pneumonia
NCT04158492
Hospital Universitari de BellvitgeN/A
Active Not RecruitingCommunity-Acquired Pneumonia Diagnosis Using Lung Ultrasound in Emergency Room Adults
NCT04210102
Centre Hospitalier Universitaire de NiceN/A
WithdrawnUse of a Rapid Diagnostic Test for Antibiotic De-escalation in Severe Community Acquired Pneumonia
NCT04781829
Northwestern UniversityN/A
CompletedStudy to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia
NCT04160260
Paratek Pharmaceuticals IncPhase 1
UnknownEvaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in Child
NCT04158310
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
TerminatedEffect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia.
NCT04071041
Jordi CarratalaPhase 3
CompletedShortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia
NCT04089787
Thomas BenfieldPhase 4
TerminatedOPEP Devices in Acute Inpatient Treatment of Pneumonia
NCT04540510
Danbury HospitalN/A
CompletedPharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Inf
NCT04350502
Centre Hospitalier Universitaire, AmiensN/A
UnknownDiagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-
NCT04043325
University Children's Hospital, Zurich
UnknownPoint-of-Care Multiplex for Adult Patients With Severe Community-acquired Pneumonia
NCT04835818
National Taiwan University HospitalN/A
UnknownPhysical Training During Hospital Admission With Community-Acquired Pneumonia
NCT04094636
Nordsjaellands HospitalN/A
CompletedDetermination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger
NCT03696303
University of Colorado, Denver
UnknownAdequate Duration of Antibiotic Treatment in Community-acquired Pneumonia With High Risk Class and Adequate In
NCT03609099
David Garcia CincaPhase 4
CompletedThe Effect of Protein Supplement on Lean Body Mass in Patients With Pneumonia
NCT03774953
Nordsjaellands HospitalN/A
RecruitingSurviving Pneumonia
NCT03795662
Nordsjaellands Hospital
UnknownMulticenter Epidemiologic Study of Severe Community Acquired Pneumonia in China
NCT03728816
Ruijin Hospital
CompletedKIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP
NCT03474991
Julia BielickiPhase 3
CompletedCombined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in
NCT03452826
Assistance Publique - Hôpitaux de ParisN/A
UnknownClinical Study of Anerning Particle for the Treatment of Childhood Community-acquired Pneumonia
NCT03675178
China Academy of Chinese Medical SciencesPhase 4
CompletedOral Nemonoxacin in Treating Elderly Patients With CAP
NCT05133752
TaiGen Biotechnology Co., Ltd.Phase 4
CompletedA Phase 1b/2a Study of the Safety and Pharmacokinetics of Rhu-plasma Gelsolin in Hospitalized Subjects With CA
NCT03466073
BioAegis Therapeutics Inc.Phase 1 / Phase 2
CompletedQuantitative Polymerase Chain Reaction for Improved Detection of Pneumococci in CAP "CAPTAIN"
NCT03315403
Medical Center Alkmaar
CompletedPharmacokinetics of XueBiJing in Patients With Sepsis
NCT03475732
Southeast University, ChinaN/A
TerminatedInnate Immune Response During Community Acquired Pneumonia
NCT03379207
University Hospital, Tours
RecruitingFulminant Severe CAP - an Observational Study
NCT06516601
University of Trieste
CompletedDescription of Pneumococcal Pneumonia
NCT03322670
CNGE Conseil
TerminatedDiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pn
NCT03360851
MJM BontenN/A
CompletedTrial of Respiratory Infections in Children for Enhanced Diagnostics
NCT03233516
Karolinska Institutet
UnknownReason Evaluation of Initial Treatment Failure in Patients With CAP
NCT03280004
Peking Union Medical College Hospital
UnknownPopulation Pharmacokinetics of Cephalosporins and Macrolides in Chinese Children With Community Acquired Pneum
NCT02775968
Beijing Children's Hospital
RecruitingTwice Daily Treatment With Amoxicillin for Non-severe Community Acquired Pneumonia.
NCT03031210
St. Justine's HospitalPhase 2 / Phase 3
CompletedStudy of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired Pneumonia
NCT05395702
SPP Pharmaclon Ltd.N/A
CompletedAvoidable Readmissions For Patients Hospitalized With Community-Acquired Pneumonia
NCT02833259
University Hospital, Grenoble
UnknownClinical Characteristics and Microbiology of Community-Acquired Pneumonia
NCT03098914
Beijing Haidian Hospital
UnknownBiomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia
NCT03146182
Gertrud Baunbaek EgelundN/A
CompletedExhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient
NCT03672994
University of Leicester
CompletedPathogen Detection and Community Acquired Pneumonia
NCT02880384
Providence Health & ServicesN/A
CompletedA Molecular Toolkit for the Microbial Investigation of Severe Community Acquired Pneumonia
NCT02963142
Imperial College London
CompletedLung Ultrasound for Community-acquired Pneumonia Diagnosis in Emergency Medicine
NCT03411824
Nantes University Hospital
CompletedShort-course Antimicrobial Therapy for Paediatric Respiratory Infections
NCT02380352
Hamilton Health Sciences CorporationPhase 4
CompletedStudy to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia
NCT02813694
Nabriva Therapeutics AGPhase 3
UnknownAdjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia
NCT02913118
Qingfeng Pharmaceutical GroupPhase 4
CompletedEarly Molecular Detection Technique Coupled With Urinary Test of Infectious Agents Responsible of Children CAP
NCT02668237
Centre Hospitalier Universitaire de Saint EtienneN/A
CompletedCRP and Thoracic Emergency Ultrasound in Pneumonia
NCT03212248
Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele
WithdrawnProcalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired Pneumonia
NCT01018199
Federal University of Minas GeraisN/A
UnknownA Registry Study on Hospitalized Patients With Community-acquired Pneumonia in Real-life of China
NCT02492425
Capital Medical University
WithdrawnA P3 Comparator Trial in Community Acquired Bacterial Pneumonia
NCT02269644
Durata Therapeutics Inc., an affiliate of Allergan plcPhase 3
CompletedIncreasing Community-acquired Pneumonia Protocol Adherence by Antibiotic Stewardship
NCT02604628
UMC UtrechtN/A
WithdrawnCorticosteroids in Community-acquired Pneumonia
NCT01631916
Hospital General de Niños Pedro de ElizaldeN/A
CompletedA Sputum Screening Test to Rule-out Pneumonia at an Early Stage
NCT03256604
University Hospital, Linkoeping
CompletedCommunity-Acquired Pneumonia : Evaluation of Corticosteroids
NCT02517489
University Hospital, ToursPhase 3
CompletedStudy to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumo
NCT02559310
Nabriva Therapeutics AGPhase 3
UnknownA Retrospective Study on Hospitalized Patients With Community-acquired Pneumonia in China (CAP-China)
NCT02489578
Capital Medical University
CompletedClinical Practice Guidelines and Impact of Audit and Feedback in the Emergency Department
NCT02427048
Denver Health and Hospital AuthorityN/A
UnknownCorticosteroid Therapy for Severe Community-Acquired Pneumonia
NCT02552342
Peking Union Medical College HospitalPhase 4
CompletedPotential Role for Echocardiography in Adult Patients With Community-Acquired Pneumonia
NCT02441855
Muğla Sıtkı Koçman University
UnknownpedCAPNETZ - Community Acquired Pneumonia (CAP) in Childhood and Adolescence
NCT04047108
Hannover Medical School
UnknownMulticenter Intervention Program to Optimize the Clinical Management of Community-acquired Pneumonia in Hospit
NCT02224716
Fundación Pública Andaluza Progreso y Salud
CompletedA Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
NCT02205112
TaiGen Biotechnology Co., Ltd.Phase 3
CompletedLung Ultrasound in Pleuritic Chest Pain
NCT02107001
University of Milan
UnknownThe Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia
NCT02203110
University Medical Centre Ljubljana
CompletedReduction of Antibiotic Therapy by Biomakers in Patients With CAP Episodes (REDUCE Study)
NCT01964495
Medical Center AlkmaarN/A
UnknownShort Duration Treatment of Non-severe Community Acquired Pneumonia
NCT01963442
Versailles HospitalPhase 2
CompletedUse of Non Steroidal Antiinflammatory Drugs in Patients With Community Acquired Pneumonia
NCT02523885
Hôpital Louis Mourier
CompletedHOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections
NCT02454114
Liverpool University Hospitals NHS Foundation TrustN/A
UnknownA Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
NCT01937832
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3
CompletedBacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine
NCT01875731
Hospital General de Niños Pedro de ElizaldeN/A
CompletedTargeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor
NCT01883869
University of KentuckyPhase 1
CompletedImproving Pneumococcal Vaccination Rates in an Ambulatory Pre-surgical Testing Setting
NCT01787838
Carilion ClinicN/A
TerminatedSanteon-CAP; Dexamethasone in Community-acquired Pneumonia
NCT01743755
St. Antonius HospitalPhase 4
CompletedClinical Reassessment Versus Procalcitonin in Order to Shorten Antibiotic Duration in Community-acquired Pneum
NCT01723644
Nantes University HospitalN/A
WithdrawnMicrobiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP
NCT01662258
University of PittsburghN/A
CompletedDelayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.
NCT01683487
University of Zurich
CompletedSafety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bac
NCT01530763
Forest LaboratoriesPhase 2 / Phase 3
WithdrawnClinical Pediatric Pneumonia Score in Critically Ill Children
NCT02139384
Loma Linda University
UnknownEffect of Simvastatin on Pneumonia Prognosis in Elderly Patients
NCT01651728
Indonesia UniversityPhase 3
CompletedSmoking Cessation Intervention in Respiratory Inpatients
NCT02922387
General Hospital of KavalaPhase 4
CompletedCollaborative Healthcare Professionals Approach in Monitoring of Patient Centered Outcomes Through Pathways
NCT01561885
Majed AljeraisyN/A
CompletedPharmacokinetics of Levofloxacin in Intensive Care Unit
NCT02018081
University Hospital, ToulousePhase 4
CompletedSuitability of Antibiotic Treatment for CAP
NCT01661920
Hospital Galdakao-UsansoloN/A
CompletedChest CT-scan for the Diagnosis of Community-acquired Pneumonia
NCT01574066
Assistance Publique - Hôpitaux de ParisN/A
UnknownMACCE in Hospitalized Patients With Community-acquired Pneumonia
NCT01773863
University of Roma La Sapienza
CompletedProton Pump Inhibitors and Risk of Community-acquired Pneumonia
NCT02555852
Canadian Network for Observational Drug Effect Studies, CNODES
CompletedSafety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP
NCT01420744
BiotestPhase 2
CompletedA Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
NCT01886053
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2
CompletedCauses and Outcomes of Community Acquired Pneumonia
NCT01336036
Oxford University Clinical Research Unit, Vietnam
CompletedCommunity-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract Infe
NCT01660204
UMC UtrechtN/A
CompletedImpact of a Multidimensional Intervention in Elderly Patients With Pneumonia
NCT01285869
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauN/A
UnknownThe Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing
NCT01236677
Capital Medical University
TerminatedNon-Interventional Open Label Prospective Observational Comparative Study On Evaluation Of Compliance Of The E
NCT01032694
Pfizer
TerminatedSafety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia
NCT01081964
IASO Pharma Inc.Phase 2
CompletedEvaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory Tract Infection
NCT01108185
Abbott
CompletedA Global Active Surveillance for Community Acquired Pneumonia
NCT00929721
PfizerN/A
CompletedCorticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial
NCT00973154
University Hospital, Basel, SwitzerlandPhase 3
CompletedFailure and Cardiovascular Events in Community-acquired Pneumonia
NCT01143155
University of Milan
CompletedPhase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients Wit
NCT01537250
TaiGen Biotechnology Co., Ltd.Phase 2
WithdrawnImpact of Statins on Cytokine Expression in Pneumonia
NCT00946166
The University of Texas Health Science Center at San AntonioPhase 4
CompletedMonotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia
NCT00818610
Swiss National Fund for Scientific ResearchPhase 4
TerminatedStudy to Proof the Clinical and Bacteriological Non-inferiority of Ampicillin/Amoxicillin Versus Moxifloxacin
NCT00887276
University of UlmPhase 4
UnknownEfficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiratio
NCT00752947
Beijing HospitalPhase 4
CompletedImproved Use of Antibiotic Guidelines in Hospital Environment
NCT00512772
KU Leuven
CompletedComparative Study of NXL103 Versus Comparator in Adults With Community Acquired Pneumonia
NCT00653172
Novexel IncPhase 2
UnknownFeasibility and Outcomes of Older Patients Hospitalization
NCT00489021
Hillel Yaffe Medical CenterN/A
TerminatedFirst Time in Man Trial for Friulimicin B
NCT00492271
MerLion Pharmaceuticals GmbHPhase 1
CompletedCommunity Acquired Pneumonia in Telemark and Ostfold
NCT00467701
Sykehuset Telemark
CompletedStandardized Emergency Care for Community Acquired Pneumonia (CAP)
NCT01963000
Klinikum Nürnberg
CompletedSafety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia
NCT00434291
TaiGen Biotechnology Co., Ltd.Phase 2
CompletedControlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired P
NCT00417326
Ono Pharmaceutical Co., Ltd.Phase 2
UnknownEpidemiology of Community Acquired Pneumonia in North Israel
NCT00390819
HaEmek Medical Center, Israel
CompletedClinical Efficacy of Amoxicillin Given Twice or Three Times a Day Among Children With Non-severe Pneumonia
NCT01200706
Federal University of BahiaPhase 4
UnknownUsefulness of Microbiological Tests in Community-Acquired Pneumonia
NCT00312741
Hospital Arnau de Vilanova
CompletedSleep Apnea Syndrome and Community Acquired Pneumonia
NCT01071421
Hospital Universitario San Juan de Alicante
UnknownComparative Study of EDP-420 Versus Another Antibiotic in the Treatment of Community Acquired Pneumonia
NCT00270517
Enanta Pharmaceuticals, IncPhase 2
UnknownObservational Study of Sepsis and Pneumonia to Develop Diagnostic Tests
NCT00258869
National Center for Genome Resources
CompletedAzithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia
NCT00140023
PfizerPhase 3
CompletedPleural Fluid and Serum Procalcitonin in Patients With Parapneumonic Pleural Effusion
NCT00646490
Chang Gung Memorial Hospital
UnknownClinical Pathway Based on Procalcitonin Levels for the Management of Community-acquired Pneumonia in Outpatien
NCT02600806
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat ValencianaPhase 4
CompletedComparison Between Amoxycillin/Clavulanic Acid and Oxacillin/Ceftriaxone for Community Acquired-pneumonia
NCT01166932
UPECLIN HC FM Botucatu UnespPhase 4
CompletedCorticoids in Severe Community-Acquired Pneumonia (CAP)
NCT00908713
Hospital Clinic of BarcelonaPhase 4
CompletedStudy Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia
NCT00079885
Wyeth is now a wholly owned subsidiary of PfizerPhase 3
UnknownEpidemiological Study on Community Acquired Pneumonia
NCT02139163
Hannover Medical School
TerminatedEfects of Noninvasive Mechanical Ventilation and Conventional Mechanical Ventilation in Patients With Severe C
NCT00523497
Hospital Privado del SurN/A
CompletedCorticosteroids in Community Acquired Pneumonea
NCT01228110
Cairo UniversityN/A